In previous studies with experimental colitis or specimen from patients, inhibition of JNK was followed by down-regulation of c-Jun phosphorylation [9] and AP-1 target genes such as cyclo-oxygenases, MCP-1, ICAM-1 or release of cytokines [9], [20] (reviewed by [21]. The gene discussed is JUN; the disease is colitis.